Radiographic downstaging was rare after neoadjuvant therapy, and RECIST response was not an effective treatment endpoint for patients with borderline resectable pancreatic cancer. The authors concluded that these patients should undergo pancreatectomy after initial therapy in the absence of metastases.
No takes yet. Share an insight, caveat, or question.
Katz et al. (2012) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: